New epilepsy drug under Real-World watch: can cenobamate tame stubborn seizures?
NCT ID NCT06716801
First seen Sep 30, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study tracks 300 adults with focal epilepsy whose seizures are not well controlled despite trying 2 or 3 other medications. Researchers will observe how adding cenobamate to their treatment affects seizure frequency over 6 to 12 months in everyday medical practice across France, Germany, and Spain. The goal is to see how many people have at least half fewer seizures and to check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL EPILEPSY WITH AND WITHOUT SECONDARY GENERALIZATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital TARNIER COCHIN
RECRUITINGParis, France, France
Contact
Conditions
Explore the condition pages connected to this study.